Plasma histamine levels (H) during adjunctive H1-receptor antagonist treatment with loratadine in patients with active inflammatory bowel disease (IBD)

Inflamm Res. 2010 Mar:59 Suppl 2:S257-8. doi: 10.1007/s00011-009-0120-9.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Colitis, Ulcerative / blood
  • Colitis, Ulcerative / drug therapy
  • Crohn Disease / blood
  • Crohn Disease / drug therapy
  • Histamine / blood*
  • Histamine H1 Antagonists / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / blood*
  • Inflammatory Bowel Diseases / drug therapy*
  • Loratadine / therapeutic use*
  • Mesalamine / therapeutic use
  • Prednisolone / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Histamine H1 Antagonists
  • Mesalamine
  • Loratadine
  • Histamine
  • Prednisolone